The distribution of cannabinoid-induced Fos expression in rat brain: Differences between the Lewis and Wistar strain

Brain Research

Volumn 921, Issue 1-2, 2001, Pages 240-255

  Arnold, Jonathon C ^a,c   Topple, Ann N ^a   Mallet, Paul E ^b   Hunt, Glenn E ^a   McGregor, Iain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW ENGLAND   (Australia)

^c University of Sydney   (Australia)

Author keywords

c fos; Cannabinoid; CP 55,940; Lewis; Strain address; Wistar

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; COCAINE; PROTEIN FOS;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ANXIETY; ARTICLE; BODY TEMPERATURE; BRAIN REGION; CATALEPSY; CONTROLLED STUDY; HYPOTHERMIA; IMMUNOREACTIVITY; LOCOMOTION; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY NERVOUS SYSTEM; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REWARD; SEPTUM PELLUCIDUM; STRAIN DIFFERENCE; STRIA TERMINALIS; TEGMENTUM;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BRAIN; CANNABINOIDS; CATALEPSY; CELL COUNT; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MARIJUANA ABUSE; MOTOR ACTIVITY; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, INBRED LEW; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0035824272     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)03127-4     Document Type: Article

References (89)

1. Amygdala and extended amygdala
2. The effects of cannabinoids on the brain
3. Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract
4. Expression of c-fos in regions of the basal limbic forebrain following intracerebroventricular corticotropin-releasing factor in unstressed or stressed male rats
5. Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine
6. Hypothermic effects of dopamine D3 receptor agonists in the island of Calleja Magna. Potentiation by D1 activation
7. Functional characteristics of the midbrain periaqueductal gray
8. How toxic is cocaine?
9. Acute cocaine effects on stereotype and defense: An ethoexperimental approach
10. Genetic analysis of behavioral, neuroendocrine, and biochemical parameters in inbred rodents - Initial studies in Lewis and Fischer 344 rats and in A/J and C57BL/6J mice
11. The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats
12. Severe reduction of rat defensive behavior to a predator by discrete hypothalamic chemical lesions
13. Fos-like immunoreactivity in the periaqueductal gray of rats exposed to a natural predator
14. The periaqueductal gray and defensive behavior: Functional representation and neuronal organization
15. Conditioned fear to context is associated with increased Fos expression in the caudal ventrolateral region of the midbrain periaqueductal gray
16. 9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis study
17. Are different parts of the extended amygdala involved in fear versus anxiety?
18. Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses
19. 'When a rat smells a cat': The distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor
20. Animal model for investigating the anxiogenic effects of self-administered cocaine
21. 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212
22. 9-tetrahydrocannabinol on sleep patterns in man
23. 9-tetrahydrocannabinol
24. 9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors
25. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
26. Marijuana's interaction with brain reward systems: Update 1991
27. Cannabinoid transmission and reward-related events
28. Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR 141716A
29. Induction of the Krox 24 transcription factor in striosomes by a cannabinoid agonist
30. Adverse effects of cannabis
31. Drugs of abuse and immediate-early genes in the forebrain
32. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
33. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
34. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system
35. Rewarding brain stimulation induces only sparse fos-like immunoreactivity in dopaminergic neurons
36. The pedunculopontine tegmental nucleus: Where the striatum meets the reticular formation
37. Are neurochemistry and reinforcement enough? Can the abuse potential of drugs be explained by common actions on a dopamine reward system in the brain?
38. Deep and superficial noxious stimulation increases Fos-like immunoreactivity in different regions of the midbrain periaqueductal grey of the rat
39. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion
40. Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains
41. N-methyl-D-aspartate lesions of the pedunculopontine nucleus block acquisition and impair maintenance of responding reinforced with brain stimulation
42. 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains
43. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: Evidence supporting periaqueductal gray involvement
44. How do genes influence marijuana use? The role of subjective effects
45. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
46. Activation of multiple transcription factor genes by tetrahydrocannabinol in rat forebrain
47. Generalization of a restraint-induced discriminative stimulus to cocaine in rats
48. 9-THC and anandamide induced c-fos expression in the rat forebrain
49. Cannabinoid modulation of rat pup ultrasonic vocalizations
50. Aversive effects of the synthetic cannabinoid CP 55,940 in rats
51. Anandamide may mediate sleep induction
52. 9-tetrahydrocannabinol
53. 9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain
54. Neurobiological constraints on behavioral models of motivation
55. Effects of pedunculopontine tegmental nucleus lesions on morphine-induced conditioned place preference and analgesia in the formalin test
56. Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement
57. 9-THC and cannabinoid (CB1) receptor gene expression in mice
58. THC-induced place and taste aversions in Lewis and Sprague-Dawley rats
59. Arachidonylethanolamide (AEA) activation of Fos proto-oncogene protein immunoreactivity in the rat brain
60. 9-tetrahydrocannabinol is enhanced by chlorpromazine, thioxanthenes, alpha-adrenoceptor antagonists and pentolinium but not by SCH 23390 or sulpiride
61. 9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide
62. Immunohistochemical localization of the neural cannabinoid receptor in rat brain
63. 9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain
64. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: Opposite and synergistic functional interactions
65. Stress and interleukin-1 beta-induced activation of c-fos, NGFI-B and CRF gene expression in the hypothalamic PVN: Comparison between Sprague-Dawley, Fisher-344 and Lewis rats
66. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal
67. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats
68. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze
69. From normal fear to pathological anxiety
70. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: An in situ hybridization study
71. Behavioral functions of nucleus accumbens dopamine: Empirical and conceptual problems with the anhedonia hypothesis
72. Hyperthermia induces c-fos expression in the preoptic area
73. CNS cell groups projecting to sympathetic outflow of tail artery: Neural circuits involved in heat loss in the rat
74. The distribution of 3,4-methylenedioxymethamphetamine 'Ecstasy'-induced c-fos expression in rat brain
75. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats
76. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats
77. What is the amygdala?
78. In vitro sensitivity of median preoptic neurons to angiotensin II, osmotic pressure, and temperature
79. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
80. Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains
81. 9-tetrahydrocannabinol and anandamide enhances the ability of muscimol to induce catalepsy in the globus pallidus of rats
82. Adverse effects of stimulant drugs in a community sample of drug users
83. On the relationships between the striatum and the pedunculopontine tegmental nucleus
84. Regulation of daily rhythm of body temperature by neurotensin receptor in rats
85. Anxiogenic effects of acute and chronic cocaine administration: Neurochemical and behavioral studies
86. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors